The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Deep brain stimulation for intractable trigeminal autonomic cephalalgias.
NICE has also published guidance on deep brain stimulation for refractory chronic pain syndromes (excluding headache) (NICE interventional procedure guidance 382, March 2011).
Trigeminal autonomic cephalalgias (TACs) are characterised by frequent severe headache attacks that last for short periods. The headaches are usually accompanied by tears, sweating, flushing, and a runny nose on the same side of the head as the pain. Deep brain stimulation has been introduced to treat TACs that do not respond to other treatments. It aims to mask the pain by delivering electrical impulses to a precise area of the brain using an electrode.
A09.1 Implantation of neurostimulator into brain
Y53.3 Approach to organ under computed tomography scan control
Includes: Approach to organ under stereotactic control
Y53.7 Approach to organ under magnetic resonance imaging control
In addition an ICD-10 code from category G44.- Other headache syndromes or code R51.X Headache is assigned.
This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.